![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2020
Neff, Andrina; Chok, Lionel; Both, Ulrich von; Matt, Ulrich; Tarnutzer, Andrea; Andreoni, Federica; Linden, Mark van der; Plock, Jan A.; Buehler, Philipp K.; Brugger, Silvio D.; Schuepbach, Reto A.; Zbinden, Reinhard und Zinkernagel, Annelies S.
(2020):
Characterisation of clinical manifestations of and treatment strategies for invasive beta-haemolytic streptococcal infections in a Swiss tertiary hospital.
In: Swiss Medical Weekly, Bd. 150, w20378
2018
Weinberger, Raphael; Kries, Rüdiger von; Linden, Mark van der; Rieck, Thorsten; Siedler, Anette und Falkenhorst, Gerhard
(2018):
Invasive pneumococcal disease in children under 16 years of age: Incomplete rebound in incidence after the maximum effect of PCV13 in 2012/13 in Germany.
In: Vaccine, Bd. 36, Nr. 4: S. 572-577
2016
Weinberger, Raphael; Falkenhorst, Gerhard; Bogdan, Christian; Linden, Mark van der; Imöhl, Matthias und Kries, Rüdiger von
(2016):
Incidence of invasive pneumococcal disease in 5-15 year old children with and without comorbidities in Germany after the introduction of PCV13: Implications for vaccinating children with comorbidities (vol 33, pg 6617, 2015).
In: Vaccine, Bd. 34, Nr. 15: S. 1861
Weinberger, Raphael; Linden, Mark van der; Imöhl, Matthias und Kries, Rüdiger von
(2016):
Vaccine effectiveness of PCV13 in a 3+1 vaccination schedule.
In: Vaccine, Bd. 34, Nr. 18: S. 2062-2065
2010
Rueckinger, Simon; Linden, Mark van der und Kries, Rüdiger von
(2010):
Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants.
In: BMC Infectious Diseases
10:12
[PDF, 194kB]